letrozole AI
Selected indexed studies
- Palbociclib and Letrozole in Advanced Breast Cancer. (N Engl J Med, 2016) [PMID:27959613]
- Ribociclib plus Endocrine Therapy in Early Breast Cancer. (N Engl J Med, 2024) [PMID:38507751]
- Letrozole: Pharmacology, toxicity and potential therapeutic effects. (Life Sci, 2022) [PMID:36243120]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Palbociclib and Letrozole in Advanced Breast Cancer. (2016) pubmed
- Letrozole: Pharmacology, toxicity and potential therapeutic effects. (2022) pubmed
- Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. (2022) pubmed
- Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3. (2024) pubmed
- Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature. (2016) pubmed
- Ribociclib plus Endocrine Therapy in Early Breast Cancer. (2024) pubmed
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study. (2015) pubmed
- Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study. (2025) pubmed
- The Combination of Aromatase Inhibitors and GH Treatment for Idiopathic Short Stature in Male Adolescents. (2025) pubmed
- The discovery and mechanism of action of letrozole. (2007) pubmed